Ld. Wise et al., DEVELOPMENTAL NEUROTOXICITY EVALUATION OF THE AVERMECTIN PESTICIDE, EMAMECTIN BENZOATE, IN SPRAGUE-DAWLEY RATS, Neurotoxicology and teratology, 19(4), 1997, pp. 315-326
The potential of emamectin benzoate (EB) to cause developmental neurot
oxicity in Sprague-Dawley rats was assessed using a study design propo
sed by the US EPA. Dosages of 0 (deionized water), 0.1, 0.6, or 3.6 mg
/kg/day were administered at 5 ml/kg by oral gavage from gestational d
ay (GD) 6 to lactational day (LD) 20 to groups of 25 mated females eac
h. Between GD 17 and 20 the high dose was reduced to 2.5 mg/kg/day bec
ause of pup tremors observed at this dose level in a concurrent two-ge
neration study. Females were allowed to deliver and the young were eva
luated for survival, growth, development, behavior, and histological c
hanges to brain, spinal cord, peripheral nerve, and skeletal muscle. B
ehavioral assessment of the offspring consisted of open field motor ac
tivity, auditory startle habituation, and passive avoidance tests; eac
h was conducted on weanling and adult animals (one animal/sex/litter).
Histopathological examination of the CNS and PNS was conducted on one
animal/sex/litter on postnatal days (PND) 11 and 60. There were signi
ficant increases in average F-0 maternal body weight gains during gest
ation in the 0.6 and 3.6/2.5 mg/kg/day groups, but no other effects we
re observed in pregnant females of these or the low-dose groups during
the study. Beginning on PND 6, tremors were observed in high-dose pup
s, and this was followed by hindlimb splay in all high-dose pups by PN
D 15-26. Both of these physical signs disappeared by PND 34 (i.e., 10-
11 days after weaning). There were no compound-related deaths in F-1 o
ffspring. Beginning on PND 11, progressive decreases in preweaning ave
rage weights were observed in the high-dose group (to 42% below contro
l in females on PND 21). Average weight gain during the postweaning pe
riod was significantly decreased in the 3.6/2.5 mg/kg/day group. There
were EB-related effects in behavioral tests only in the high-dose gro
up. A significant increase in PND 13 average horizontal motor activity
was due to stereotypical movements. Average horizontal activity was d
ecreased on PND 17 and in adult females, but there were no effects on
PND 21. Average peak auditory startle response amplitude was decreased
on PND 22 and in adults. There were no EB-related effects in the pass
ive avoidance test, relative brain weights, or in the histological exa
mination (including morphometry) of the nervous system, These results
demonstrate that the high-dose EB exposure during gestation and lactat
ion to rats produced evidence of neurotoxicity in the F-1 offspring, a
nd a clear No Observed Adverse Effect Level (NOAEL) for developmental
neurotoxicity of EB was determined to be 0.6 mg/kg/day. (C) 1997 Elsev
ier Science Inc.